Zinc Oxide
Active ingredient
Sold as Empower · GeriGard · Dew Me · Inde Wild · CoTZ Baby
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Topical, Cutaneous
- Markets covered
- 3
- Products on record
- 318
- FDA reports (12 mo)
- 181
Overview
Plain-language summary, compiled from the cited regulatory records
Zinc Oxide is an active ingredient used in sun protection products [1]. It is approved to help prevent sunburn [1]. When used as directed with other sun protection measures, it can decrease the risk of skin cancer and early skin aging caused by the sun [1].
This ingredient is available under various brand names, including Eminence Radiant Protection SPF Fluid and Botnia Gentle Sun SPF 30 [1]. In the past 12 months, there have been 181 adverse event reports associated with products containing Zinc Oxide [2]. The most frequently reported issues include off-label use, the drug being ineffective, nausea, cholelithiasis, and aggravation of a condition [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 264 | May 26, 2026 |
| GB United Kingdom | MHRA | 15 | March 27, 2026 |
| CA Canada | Health Canada | 39 | March 4, 2026 |
USUnited States· FDA
264 products
Uses
Uses Helps prevent sunburn. Higher SPF gives more sunburn protection If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
How to take
GBUnited Kingdom· MHRA
15 products
Uses
The symptomatic relief of pain, swelling, irritation and itching associated with haemorrhoids, and pruritus ani.
How to take
CACanada· Health Canada
39 products
39 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Sources & citations
- [1]FDA DailyMed · 005d0245-fe53-47… · revised March 3, 2026 [PDF]
- [2]MHRA (UK) · PL000100264 · revised March 13, 2026
- [3]Health Canada (DPD) · 02239160 · revised August 20, 2025
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.